chr4-74381045-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001432.3(EREG):​c.186A>T​(p.Gln62His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000382 in 1,613,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 0 hom. )

Consequence

EREG
NM_001432.3 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.652
Variant links:
Genes affected
EREG (HGNC:3443): (epiregulin) This gene encodes a secreted peptide hormone and member of the epidermal growth factor (EGF) family of proteins. The encoded protein is a ligand of the epidermal growth factor receptor (EGFR) and the structurally related erb-b2 receptor tyrosine kinase 4 (ERBB4). The encoded protein may be involved in a wide range of biological processes including inflammation, wound healing, oocyte maturation, and cell proliferation. Additionally, the encoded protein may promote the progression of cancers of various human tissues. [provided by RefSeq, Jul 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18122813).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
EREGNM_001432.3 linkuse as main transcriptc.186A>T p.Gln62His missense_variant 3/5 ENST00000244869.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
EREGENST00000244869.3 linkuse as main transcriptc.186A>T p.Gln62His missense_variant 3/51 NM_001432.3 P1
EREGENST00000507603.1 linkuse as main transcriptn.322A>T non_coding_transcript_exon_variant 3/32

Frequencies

GnomAD3 genomes
AF:
0.000315
AC:
48
AN:
152248
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000676
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000255
AC:
64
AN:
250970
Hom.:
0
AF XY:
0.000265
AC XY:
36
AN XY:
135654
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000554
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000389
AC:
568
AN:
1461444
Hom.:
0
Cov.:
30
AF XY:
0.000355
AC XY:
258
AN XY:
727000
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000749
Gnomad4 NFE exome
AF:
0.000491
Gnomad4 OTH exome
AF:
0.000265
GnomAD4 genome
AF:
0.000315
AC:
48
AN:
152248
Hom.:
0
Cov.:
32
AF XY:
0.000242
AC XY:
18
AN XY:
74384
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000676
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000467
Hom.:
0
Bravo
AF:
0.000268
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000288
AC:
35
EpiCase
AF:
0.000327
EpiControl
AF:
0.000296

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 16, 2021The c.186A>T (p.Q62H) alteration is located in exon 3 (coding exon 3) of the EREG gene. This alteration results from a A to T substitution at nucleotide position 186, causing the glutamine (Q) at amino acid position 62 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.52
D
Eigen
Uncertain
0.22
Eigen_PC
Benign
0.13
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.0059
T
MetaRNN
Benign
0.18
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.8
M
MutationTaster
Benign
0.59
N
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.097
Sift
Benign
0.037
D
Sift4G
Uncertain
0.0090
D
Polyphen
0.99
D
Vest4
0.40
MutPred
0.37
Loss of catalytic residue at Q62 (P = 0.0494);
MVP
0.17
MPC
0.079
ClinPred
0.14
T
GERP RS
-0.064
Varity_R
0.095
gMVP
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145916659; hg19: chr4-75246762; API